These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37906254)

  • 1. SARS-CoV-2 seroprevalence in patients with autoimmune rheumatic diseases versus family controls: a multi-city cross-sectional survey.
    Misra R; Bhattacharya D; Ahmed S; Amin S; Shobha V; Ghosh A; Pandya SC; Parai D; Padhan P; Priyadarshini S; Mohapatra I; Patro ARK; Mohanty AP; Pati S
    Rheumatol Int; 2024 Jan; 44(1):81-87. PubMed ID: 37906254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroprevalence of SARS-CoV-2 antibodies in patients with autoimmune inflammatory rheumatic diseases.
    Eviatar T; Furer V; Polachek A; Levartovsky D; Elalouf O; Zisapel M; Halperin T; Turner D; Paran D; Pel S; Nevo S; Elkayam O
    Clin Exp Rheumatol; 2022 Jul; 40(7):1299-1305. PubMed ID: 34494961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asymptomatic SARS-CoV-2 seropositivity: patients with childhood-onset rheumatic diseases versus healthy children.
    Haslak F; Ozbey D; Yildiz M; Adrovic A; Sahin S; Koker O; Aliyeva A; Guliyeva V; Yalcin G; Inanli G; Kocazeybek BS; Kasapcopur O; Barut K
    Clin Rheumatol; 2022 May; 41(5):1523-1533. PubMed ID: 35044502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variability in detection of SARS-CoV-2-specific antibody responses following mild infection: a prospective multicentre cross-sectional study, London, United Kingdom, 17 April to 17 July 2020.
    Pallett SJ; Jones R; Abdulaal A; Pallett MA; Rayment M; Patel A; Denny SJ; Mughal N; Khan M; Rosadas de Oliveira C; Pantelidis P; Randell P; Toumazou C; O'Shea MK; Tedder R; McClure MO; Davies GW; Moore LS
    Euro Surveill; 2022 Jan; 27(4):. PubMed ID: 35086612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody responses after documented COVID-19 disease in patients with autoimmune rheumatic disease.
    Shenoy P; Ahmed S; Shanoj KC; Shenoy V; Damodaran D; Menon AR; Alias B; SanjoSaijan ; Devakumar D; Babu ASS
    Clin Rheumatol; 2021 Nov; 40(11):4665-4670. PubMed ID: 34155573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-cell RNA sequencing to decipher the immunogenicity of ChAdOx1 nCoV-19/AZD1222 and mRNA-1273 vaccines in patients with autoimmune rheumatic diseases.
    Chen YJ; Cheng PL; Huang WN; Chen HH; Chen HW; Chen JP; Lin CT; Tang KT; Hung WT; Hsieh TY; Chen YH; Chen YM; Hsiao TH
    Front Immunol; 2022; 13():920865. PubMed ID: 35979368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroprevalence and clinical outcomes of SARS-CoV-2 in paediatric patients with rheumatic disease.
    Walters HM; Mian Z; Thomas L; Cerise J; Eberhard BA; Pagano E; Gottlieb BS; Steigerwald K; Hui-Yuen JS
    Rheumatology (Oxford); 2022 Jun; 61(SI2):SI112-SI119. PubMed ID: 34599820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Favorable antibody responses to human coronaviruses in children and adolescents with autoimmune rheumatic diseases.
    Deakin CT; Cornish GH; Ng KW; Faulkner N; Bolland W; Hope J; Rosa A; Harvey R; Hussain S; Earl C; Jebson BR; Wilkinson MGLL; Marshall LR; O'Brien K; Rosser EC; Radziszewska A; Peckham H; Patel H; Heaney J; Rickman H; Paraskevopoulou S; Houlihan CF; Spyer MJ; Gamblin SJ; McCauley J; Nastouli E; Levin M; Cherepanov P; Ciurtin C; Wedderburn LR; Kassiotis G
    Med; 2021 Sep; 2(9):1093-1109.e6. PubMed ID: 34414384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients series.
    Ferri C; Giuggioli D; Raimondo V; L'Andolina M; Tavoni A; Cecchetti R; Guiducci S; Ursini F; Caminiti M; Varcasia G; Gigliotti P; Pellegrini R; Olivo D; Colaci M; Murdaca G; Brittelli R; Mariano GP; Spinella A; Bellando-Randone S; Aiello V; Bilia S; Giannini D; Ferrari T; Caminiti R; Brusi V; Meliconi R; Fallahi P; Antonelli A;
    Clin Rheumatol; 2020 Nov; 39(11):3195-3204. PubMed ID: 32852623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of antibodies against SARS-CoV-2 in the Norwegian population, August 2021.
    Tunheim G; Rø GØI; Chopra A; Aase A; Kran AB; Vaage JT; Lund-Johansen F; Hungnes O
    Influenza Other Respir Viruses; 2022 Nov; 16(6):1004-1013. PubMed ID: 35770841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct anti-NP, anti-RBD and anti-Spike antibody profiles discriminate death from survival in COVID-19.
    Servian CDP; Spadafora-Ferreira M; Dos Anjos DCC; Guilarde AO; Gomes-Junior AR; Borges MASB; Masson LC; Silva JMM; de Lima MHA; Moraes BGN; Souza SM; Xavier LE; de Oliveira DCA; Batalha-Carvalho JV; Moro AM; Bocca AL; Pfrimer IAH; Costa NL; Feres VCR; Fiaccadori FS; Souza M; Gardinassi LG; Durigon EL; Romão PRT; Jorge SAC; Coelho V; Botosso VF; Fonseca SG
    Front Immunol; 2023; 14():1206979. PubMed ID: 37876932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating immunity to SARS-CoV-2 in nursing home residents using saliva IgG.
    Katz MJ; Heaney CD; Pisanic N; Smith L; Bigelow BF; Sheikh F; Boudreau A; Kruczynski K; Hsu YJ; Salinas AB; Cosgrove SE; Rock C
    J Am Geriatr Soc; 2022 Mar; 70(3):659-668. PubMed ID: 35038344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study.
    Poustchi H; Darvishian M; Mohammadi Z; Shayanrad A; Delavari A; Bahadorimonfared A; Eslami S; Javanmard SH; Shakiba E; Somi MH; Emami A; Saki N; Hormati A; Ansari-Moghaddam A; Saeedi M; Ghasemi-Kebria F; Mohebbi I; Mansour-Ghanaei F; Karami M; Sharifi H; Pourfarzi F; Veisi N; Ghadimi R; Eghtesad S; Niavarani A; Ali Asgari A; Sadeghi A; Sorouri M; Anushiravani A; Amani M; Kaveh S; Feizesani A; Tabarsi P; Keyvani H; Markarian M; Shafighian F; Sima A; Sadjadi A; Radmard AR; Mokdad AH; Sharafkhah M; Malekzadeh R
    Lancet Infect Dis; 2021 Apr; 21(4):473-481. PubMed ID: 33338441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the SARS-CoV-2 antibody landscape in Norway in the late summer of 2022: high seroprevalence in all age groups with patterns of primary Omicron infection in children and hybrid immunity in adults.
    Tunheim G; Fossum E; Robertson AH; Rø GØI; Chopra A; Vaage JT; Vikse EL; Kran AB; Magnus P; Trogstad L; Mjaaland S; Hungnes O; Lund-Johansen F
    BMC Infect Dis; 2024 Aug; 24(1):841. PubMed ID: 39164637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgG antibodies to SARS-CoV-2 in asymptomatic blood donors at two time points in Karachi.
    Hasan M; Moiz B; Qaiser S; Masood KI; Ghous Z; Hussain A; Ali N; Simas JP; Veldhoen M; Alves P; Abidi SH; Ghias K; Khan E; Hasan Z
    PLoS One; 2022; 17(8):e0271259. PubMed ID: 36001587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 Infection-and mRNA Vaccine-induced Humoral Immunity among Schoolchildren in Hawassa, Ethiopia.
    Merid Y; Tekleselasie W; Tesfaye E; Gadisa A; Fentahun D; Abate A; Alemu A; Mihret A; Mulu A; Gelanew T
    Front Immunol; 2023; 14():1163688. PubMed ID: 37398668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases.
    Freites Nuñez DD; Leon L; Mucientes A; Rodriguez-Rodriguez L; Font Urgelles J; Madrid García A; Colomer JI; Jover JA; Fernandez-Gutierrez B; Abasolo L
    Ann Rheum Dis; 2020 Nov; 79(11):1393-1399. PubMed ID: 32769150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical course and seroprevalence of COVID-19 in children with rheumatic diseases-cross-sectional study from a reference centre in Spain.
    Udaondo C; Millán-Longo C; Permuy C; Valladares L; Falces-Romero I; Muñoz-Gómez C; Morales-Higuera M; Alcobendas R; Remesal A; Murias S; Calvo C
    Clin Rheumatol; 2022 Jun; 41(6):1779-1784. PubMed ID: 35489011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 seroprevalence among the general population and healthcare workers in India, December 2020-January 2021.
    Murhekar MV; Bhatnagar T; Thangaraj JWV; Saravanakumar V; Kumar MS; Selvaraju S; Rade K; Kumar CPG; Sabarinathan R; Turuk A; Asthana S; Balachandar R; Bangar SD; Bansal AK; Chopra V; Das D; Deb AK; Devi KR; Dhikav V; Dwivedi GR; Khan SMS; Kumar MS; Laxmaiah A; Madhukar M; Mahapatra A; Rangaraju C; Turuk J; Yadav R; Andhalkar R; Arunraj K; Bharadwaj DK; Bharti P; Bhattacharya D; Bhat J; Chahal AS; Chakraborty D; Chaudhury A; Deval H; Dhatrak S; Dayal R; Elantamilan D; Giridharan P; Haq I; Hudda RK; Jagjeevan B; Kalliath A; Kanungo S; Krishnan NN; Kshatri JS; Kumar A; Kumar N; Kumar VGV; Lakshmi GGJN; Mehta G; Mishra NK; Mitra A; Nagbhushanam K; Nimmathota A; Nirmala AR; Pandey AK; Prasad GV; Qurieshi MA; Reddy SD; Robinson A; Sahay S; Saxena R; Sekar K; Shukla VK; Singh HB; Singh PK; Singh P; Singh R; Srinivasan N; Varma DS; Viramgami A; Wilson VC; Yadav S; Yadav S; Zaman K; Chakrabarti A; Das A; Dhaliwal RS; Dutta S; Kant R; Khan AM; Narain K; Narasimhaiah S; Padmapriyadarshini C; Pandey K; Pati S; Patil S; Rajkumar H; Ramarao T; Sharma YK; Singh S; Panda S; Reddy DCS; Bhargava B;
    Int J Infect Dis; 2021 Jul; 108():145-155. PubMed ID: 34022338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroprevalence of IgG antibodies against SARS-CoV-2 among the general population and healthcare workers in India, June-July 2021: A population-based cross-sectional study.
    Murhekar MV; Bhatnagar T; Thangaraj JWV; Saravanakumar V; Santhosh Kumar M; Selvaraju S; Rade K; Kumar CPG; Sabarinathan R; Asthana S; Balachandar R; Bangar SD; Bansal AK; Bhat J; Chakraborty D; Chopra V; Das D; Devi KR; Dwivedi GR; Jain A; Khan SMS; Kumar MS; Laxmaiah A; Madhukar M; Mahapatra A; Ramesh T; Rangaraju C; Turuk J; Yadav S; Bhargava B;
    PLoS Med; 2021 Dec; 18(12):e1003877. PubMed ID: 34890407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.